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E-mail address: skulach@genebee.msu.ru (V.P. SkuA conjugate of plastoquinone with decylrhodamine 19 (SkQR1) selectively accumulates in mito-
chondria of normal and tumor cells. SkQR1 protected the cellular pool of reduced glutathione under
oxidative stress. Overexpression of P-glycoprotein (Pgp 170) multidrug resistance pump strongly
suppresses accumulation of SkQR1. The inhibitors of Pgp 170 stimulate accumulation of SkQR1 in
various cell lines indicating that SkQR1 is a substrate of Pgp 170. The protective effect of SkQR1
against oxidative stress is diminished in the cells overexpressing Pgp 170. It is suggested that mito-
chondria-targeted antioxidants could selectively protect normal (Pgp 170-negative) cells against the
toxic effect of anti-cancer treatments related to oxidative stress.
 2009 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.1. Introduction
Mitochondria are one of the major sources for production of
reactive oxygen species (ROS) and at the same time one of the crit-
ical targets of ROS-induced damage to the cell [1–3]. Recently a no-
vel approach based on mitochondrial targeting of bioactive
molecules has been developed (reviewed in [4]). The most popular
targeting strategy consists in conjugation of an active molecule
with a vehicle that accumulates in the mitochondria due to its po-
sitive charge since mitochondria is the only negatively charged
compartment of the cell. Penetrating cations necessary for this
purpose were developed by one of us [5] and an idea of electropho-
retic accumulation of uncharged molecules conjugated with these
cations as with ‘‘molecular electric locomotives” was introduced
soon after this [6]. This approach was realized for the ﬁrst time
to deliver antioxidants thiobutyl, vitamin E and ubiquinone to
mitochondria by Murphy and co-workers [7]. Recently we have
developed the novel more effective mitochondria-targeted antiox-on behalf of the Federation of Euro
decyltriphenylphosphonium;
MDR, multidrug resistance;
es; MTT, 3-(4,5-dimethylthi-
5,50-dithio-bis(2-nitrobenzoic
romethyl-20 ,70-dichlorodihy-
lachev).idants based on cationic conjugates of plastoquinone [8–10]. Cat-
ions of triphenylphosphonium and rhodamine 19 were shown to
be the most effective vehicles in artiﬁcial lipid membranes and in
isolated mitochondria. The corresponding compounds named 10-
(60-plastoquinonyl) decyltriphenylphosphonium (SkQ1) and 10-
(60-plastoquinonyl) decylrhodamine 19 (SkQR1), respectively, have
high antioxidant efﬁciency in living cells and in animal models
[9,11].pean Biochemical Societies.
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during chemotherapy and responsible for decrease in efﬁciency of
traditional chemotherapy of cancer. In the majority of human tu-
mors, this phenomenon is related to overexpression of a 170–
180 kDa plasma membrane glycoprotein (Pgp 170) [12,13]. This
ATPase belongs to the superfamily of ATP-binding cassette trans-
porters (ABC) and actively extrudes a wide range of structurally di-
verse drugs used for chemotherapy of cancer. The positively
charged rather lipophilic compounds are extruded with maximal
efﬁciency. The mitochondria-targeted antioxidants perfectly ﬁt
the requirements to substrates for Pgp 170. If so, these antioxi-
dants could be used to protect of normal tissues against toxicity
of anti-cancer drugs that are often inducing ROS overproduction
in mitochondria and oxidative damage of these organelles. As to
tumor cells, they will remain unprotected since SkQ will be ex-
truded from these cells by Pgp 170.
In this work, we have shown that SkQR1 is a good substrate of
Pgp 170 and selectively protects MDR-negative cells from oxida-
tive stress.
2. Materials and methods
Reagents for cell culture were from Gibco, Mitotracker Green
and 5-(and-6)-chloromethyl-20,70-dichlorodihydroﬂuorescein diac-
etate (CM-DCFH-DA) were from Molecular Probes. SkQ1 and
SkQR1 were synthesized in our laboratory as described early
[8,9]. Pluronic L61 was a kind gift of Dr. N.S. Melik-Nubarov (A.N.
Belozersky Institute, Moscow State University). The other reagents
were from Sigma–Aldrich (USA).Fig. 1. Accumulation of SkQR1 in mitochondria of HeLa cells. (A) Confocal images of t
(200 nM, 15 min). Where indicated, 10 lM FCCP was added 15 min before SkQR1 (Mitot
After 3 h incubation, SkQR1 was washed out (dotted line) and its release was measured
ﬂuorescence are shown. (C) Reduced glutathione was measured after 2 h of incubation wi
FCCP was added simultaneously with SkQ1.2.1. Cell culture
Normal human subcutaneous ﬁbroblasts (Cell Collection, Insti-
tute of Medical Genetics, Russian Academy of Medical Sciences,
Moscow), cervical carcinoma Hela, and breast carcinoma MCF-7
were cultivated in DMEM medium supplemented with 10% fetal
calf serum, penicillin (100 U/ml) and streptomycin (100 U/ml). Hu-
man erythroleukemia K562 was cultivated in RPMI 1640 medium
with the same additions. Cells were grown in humidiﬁed atmo-
sphere containing 5% CO2 at 37 C. MCF-7 [14] and K562 [15] sub-
lines with high level of MDR (the kind gift of Dr. N.S. Melik-
Nubarov) were selected for resistance to doxorubicin. Overexpres-
sion of Pgp 170 was conﬁrmed by Western analysis [14,15].
2.2. Intracellular accumulation of SkQR1
Intracellular accumulation of SkQR1 was detected using
confocal microscope (Carl Zeiss with LSM 510 equipment) and
measured by FACS (Beckman-Coulter FC500). Staining with Mito-
tracker Green (200 nM, 15 min) was used for visualization of
mitochondria.
2.3. Non-protein thiols
Non-protein thiols (mainly reduced glutathione) were mea-
sured after mixing of cells suspended in PBS with solution contain-
ing 5% HClO4, 2.5% Triton X-100, and 2.5 mM EDTA, in the ratio of
1:1. Denatured proteins were separated by centrifugation. Thiols
were measured by reduction of 6 mM 5,50-dithio-bis(2-nitroben-
zoic acid) (DTNB) in 250 mM sodium phosphate (pH 7.5) andhe cells incubated with 50 nM SkQR1 for 3 h and stained with Mitotracker Green
racker Green was omitted). (B) Accumulation of SkQR1 (50 nM) measured by FACS.
. In the separate assay, 10 lM FCCP was added after washing. The mean values of
th 1 mM H2O2. SkQ1 and SkQR1 were added 2 h before H2O2. Where indicated, 5 lM
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reagent.
2.4. Cell viability
Cell viability was analyzed by reduction of 3-(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyltetrazolium bromide (MTT assay) using
microplate reader as described [16]. Apoptotic cells were stained
with Hoechst 33342 (1 lg/ml) for 30 min and apoptotic nuclei
were counted using Axiovert microscope (Carl Zeiss).
2.5. Statistical analysis
Each assay was performed at least three times. The data were
expressed as mean ± SD and Student’s t-test was used to determine
the signiﬁcance of differences in multiple comparisons. P < 0.05
was considered to be statistically signiﬁcant.Fig. 2. Effects of inhibitors of multidrug resistance on accumulation of SkQR1.
Accumulation of SkQR1 (50 nM) measured by FACS in HeLa cells (A) and ﬁbroblasts
(B). Verapamil (50 lM) and pluronic L61 (30 lg/ml), inhibitors of multidrug
resistance, were added 1 h before SkQR1. After 3 h of incubation, SkQR1 was
washed out (dotted line) and, where indicated, the inhibitors were added.3. Results and discussion
3.1. SkQR1 is selectively accumulated in mitochondria of normal and
tumor cell
HeLa cells were incubated with SkQR1 (50 nM) for 3 h and then
stained with Mitotracker Green, speciﬁc mitochondrial dye
(Fig. 1A). Confocal images demonstrated complete colocalization
of two dyes, indicating that SkQR1 was selectively accumulated
in mitochondria. The detailed analysis of the images revealed that
(i) all mitochondria in the cell accumulated SkQR1 and (ii) no other
organelles were stained with SkQR1. The protonophorous uncou-
pler FCCP, that caused mitochondrial membrane depolarization
prevented SkQR1 accumulation (Fig. 1A) in full agreement with
an assumption that this antioxidant is electrophoretically accumu-
lated in mitochondria. Similar images demonstrating selective
accumulation of SkQR1 in mitochondria were obtained for the
other cell lines used here, namely normal human subcutaneous
ﬁbroblasts, HepG2, MCF-7, K562 (not shown).
Dynamics of SkQR1 accumulation in HeLa cells was studied
using ﬂow cytometry. It was found that accumulation of SkQR1
takes approx. 2 h and reached a plateau (Fig. 1B). The amount of
accumulated dye was proportional to the SkQR1 concentration
but kinetics of the process proved to be concentration independent
within the range 20–1000 nM (data not shown). The latter effect
might be due to that SkQR1 formed a complex with serum albumin
(which was present in high excess in the culture medium) and
could play a role of ‘‘SkQR1 buffer”. Release of SkQR1 from the cells
after washing was practically completed in 3 h. It was strongly
accelerated by FCCP, indicating that release of the dye from mito-
chondria was rate-limiting for the whole process. Interestingly,
prolonged (24 h) incubation with SkQR1 resulted in much slower
release and some staining of mitochondria was detected even after
48 h of washing (not shown).
To analyze antioxidant effect of SkQR1, we have studied oxi-
dation of gluthatione induced by hydrogen peroxide in HeLa
cells. Glutathione (GSH) is a major intracellular redox buffer
[16] and its depletion caused by H2O2 results in an oxidative
stress. Incubation of the cells with 2 nM SkQR1 for 4 h almost
completely prevented depletion of GSH (Fig. 1C). The parental
antioxidant of SkQ family, SkQ1 demonstrated the same efﬁ-
ciency in this model. FCCP ceased the protective effect of SkQ1
conﬁrming the critical role of their accumulation in mitochon-
dria. These data are in perfect agreement with high antioxidant
activity of SkQ1 and SkQR1 demonstrated earlier in isolated
mitochondria and in living cells where oxidative stress was de-
tected using a ROS-sensitive ﬂuorescent dye (CM-DCFH-DA).Measurements of GSH conﬁrmed the conclusion that oxidative
stress induced by exogenous H2O2 is mediated by secondary
ROS production in mitochondria [17].
3.2. SkQR1 is a substrate of the multidrug efﬂux protein Pgp 170
(MDR1)
SkQR1 accumulation in HeLa cells was increased by the inhibi-
tors of multidrug efﬂux verapamil and pluronic L61 (Fig. 2A). These
inhibitors also slowed down the release of SKQR1 from the cells
upon washing. A similar effect was observed with hepatoma
HepG2 cells (not shown). Normal human subcutaneous ﬁbroblasts
accumulated almost three times more SkQR1 per cell than HeLa
(Fig. 2B). This difference was not related to different cell size or
mitochondrial content since ﬂow cytometry measurements of light
scattering and Mitotracker Green staining did not reveal any differ-
ence between the two cell types (not shown). Verapamil and plu-
ronic L61 only slightly stimulated accumulation of SkQR1 in
human ﬁbroblasts (Fig. 2B) indicating a low activity of multidrug
efﬂux pumps in these cells. High activity of multidrug efﬂux pumps
is typical for various tumor cells in culture and in situ [18,19]. They
predominantly determine the phenomenon of multidrug resis-
tance [12].
In our experiments, accumulation of SkQR1 was stimulated by
verapamil and pluronic L61 which were known as speciﬁc inhibi-
tors of the main multidrug efﬂux protein Pgp 170 [20–22]. We sug-
gested that SkQR1 is a substrate of Pgp 170. To test the role of Pgp
170 in efﬂux of SkQR1, we have used the MCF-7 and K562 cell sub-
lines with elevated expression of this protein. These sublines were
Fig. 3. Effects of SkQR1 in K562 and MCF-7 cell lines and sublines with overexpression of Pgp 170. (A) Accumulation of SkQR1 in resistant and sensitive sublines of K562 cells.
Cells were incubated with 50 nM SkQR1 for 3 h. Pluronic L61 (30 lg/ml) was added 1 h before SkQR1. Confocal microscopy. (B and C) Accumulation of SkQR1 (50 nM, 3 h) in
the resistant and sensitive sublines of K562 and MCF-7. Verapamil (50 lM) and pluronic L61 (30 lg/ml) were added 1 h before SkQR1. Measurements were made by ﬂow
cytometry. (D) Protective effect of SkQR1 in sensitive and resistant K562 sublines. Cells were pretreated with SkQR1 (10 nM) for 6 days before H2O2 addition. The sensitive
and resistant K562 sublines were incubated for 20 h with 100 lMH2O2 or 300 lMH2O2, respectively, to reach the similar toxic effect. Where indicated, pluronic L61 (5 lg/ml)
was added for 6 days together with SkQR1. Cell viability was measured by MTT-test.
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phenotype and for overexpression of Pgp 170 was conﬁrmed by
Western analysis [14,15]. Accumulation SkQR1 in the resistant
sublines of the both cell types was signiﬁcantly lower than in the
sensitive counterparts (Fig. 3B and C). Verapamil and pluronic
L61 increased an SkQR1 accumulation in the resistant sublines,
being ineffective in the sensitive ones. As a result, accumulation
of SkQR1 in the presence of the inhibitors did not differ in these
sublines. Confocal images demonstrated that the MDR inhibitors
did not modify mitochondrial localization of SkQR1 (Fig. 3). These
data conﬁrmed the leading role of Pgp 170 in the efﬂux of SkQR1.
As it was shown earlier, SkQR1 (as well as SkQ1) protected var-
ious cells from apoptosis induced by oxidative stress [4,9]. We
have studied the protective action of SkQR1 in sensitive and resis-
tant sublines of K562. Hydrogen peroxide was used to induce oxi-
dative stress and it was found that Pgp 170 overexpressing subline
is more resistant to this treatment. The inhibitors of MDR did not
sensitize these sells (even the opposite effect was observed with
pluronic L61), indicating that resistance to H2O2 was acquired dur-
ing selection procedure independently from Pgp 170 overexpres-
sion. This observation was not unexpected since doxorubicin
(used for selection) has pronounced prooxidant effect which can
induce the increase in various antioxidant defense systems [15].
We titrated the cytotoxic effect of H2O2 and treated the resistant
K562 cells with higher dose of H2O2 to reach the same level of cell
death. It was found that a 6 day pretreatment with SkQR1 strongly
protected the sensitive K562 subline against oxidative stress, while
Pgp 170 overexpressing subline remained sensitive to H2O2
(Fig. 3D). When Pgp 170 was inhibited by pluronic L61 during pre-
treatment with SkQR1, the protective action of antioxidant was re-
stored. These data clearly show that the inability of SkQR1 to
protect the resistant subline from oxidative stress is related toactivity of Pgp 170. It can be concluded that the protective action
of SkQR1 was limited by it efﬂux catalyzed by Pgp 170.
Multidrug resistance mediated by Pgp 170 is typical for various
tumors highly resistant to conventional chemotherapy [23,24]. Ele-
vation of therapeutic doses is limited by non-selective cytotoxicity
of the drugs. Cytotoxic action of some anti-cancer agents is based
upon ROS formation and induction of oxidative stress. Doxorubicin
(adriamycin), for example, induces ROS formation interacting with
the respiratory chain and cardiotoxicity of this drug is mediated by
ROS [25]. Nephrotoxicity of cisplatin also depends on excessive
ROS production [26]. It seems probable that mitochondria-targeted
antioxidants could be effective protectors against these drugs.
Since tumor cells overexpress Pgp 170, they will not be protected
or protected to much lesser extent than normal cells. The selective
protection of normal (MDR negative) cells by mitochondria-tar-
geted antioxidants could be a promising strategy for improvement
of antitumor therapy.
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